In 2023, the import value of insulin to the UK stood at 1.048 million USD. For the subsequent forecasted years, the values show a year-on-year decline:
- 2024: 1.0052 million USD (-4.08%)
- 2025: 0.96766 million USD (-3.73%)
- 2026: 0.93091 million USD (-3.80%)
- 2027: 0.89488 million USD (-3.87%)
- 2028: 0.85958 million USD (-3.94%)
The declining trend over this period results in a Compound Annual Growth Rate (CAGR) of -3.88% over the five-year forecasted span from 2024 to 2028.
Future trends to watch for include potential advancements in domestic insulin production reducing reliance on imports, as well as the development of new therapies for diabetes management which might alter insulin demand. Additionally, policy changes concerning medicinal imports post-Brexit could further impact these forecasts.
